Clozapine-induced neuroleptic malignant syndrome: an interaction between dopaminergic and purinergic systems?
Lara
D R
DR
Wolf
A L
AL
Lobato
M I
MI
Baroni
G
G
Kapczinski
F
F
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D065127:Dopamine D2 Receptor Antagonists; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000503:physiopathology*; D011983:Receptors, Purinergic / Q000187:drug effects*
D014150:Antipsychotic Agents; D065127:Dopamine D2 Receptor Antagonists; D011983:Receptors, Purinergic; D003024:Clozapine